Wnt Signaling and Prostate Cancer Bone Metastasis

Wnt 信号转导与前列腺癌骨转移

基本信息

  • 批准号:
    8254847
  • 负责人:
  • 金额:
    $ 5.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-03-01 至 2015-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The American Cancer Society estimated that in 2010 over 32,000 men have died of prostate cancer.1 Metastasis is the primary cause of death due to prostate cancer, and the most common site is bone.2 Bone metastases are incurable and associated with significant pain and morbidity. The mechanisms by which prostate cancer cells metastasize and grow in bone are not fully understood, but we hypothesize that the Wnt signaling pathways are essential.3-8 While Wnt signaling in prostate cancer bone metastases has been shown to stimulate epithelial-mesenchymal transition (EMT) and the typical osteoblastic phenotype of the metastases, its role is still unclear.9-11 Understanding the role of Wnt signaling will lead to new therapeutic targets in the prevention or treatment of bone metastasis in prostate cancer and will decrease its morbidity and mortality. This project is designed to test the central hypothesis that the Wnt signaling pathways and DKK-1 (an inhibitor of canonical and stimulator of noncanonical Wnt signaling) are important for regulation of prostate cancer proliferation, progression, and metastasis to bone. The three aims are designed to test whether: 1) Autocrine non-canonical Wnt signaling by prostate cancer increases tumor growth; 2) Paracrine canonical Wnt signaling by prostate cancer induces osteoblastic metastases; and 3) Factors released by bone resorption, in cooperation with the noncanonical Wnt pathway, promote prostate cancer growth and metastasis. We have developed a unique mouse model of prostate cancer using the canine Ace-1 prostate cancer cells to test the hypotheses. Ace-1 cells metastasize exclusively to long bones and the spine and induce osteoblastic bone metastases. In addition, the hypotheses will be tested using two-compartment in vitro co-cultures of mouse calvaria and prostate cancer cells and vossicle (neonatal mouse vertebrae)/prostate cancer co-implantation in nude mice. The proposed F32 fellowship research training plan will provide a strong basic-translational science research experience for Jessica Simmons, DVM. Dr. Simmons is an aspiring scientist whose research interests are focused in investigating the pathogenesis of prostate cancer metastases in the bone. The F32 fellowship will support Dr. Simmons' research studies as well as augment her career development. PUBLIC HEALTH RELEVANCE: Wnt signaling modulates the bone microenvironment in both development and disease. Unraveling the dialogue between of Wnt signaling between metastatic prostate cancer cells and the bone microenvironment will help elucidate new treatment targets. The results of our specific aims will be relevant to the understanding the pathogenesis of prostate cancer metastasis and discovery of new therapeutic targets for the prevention or inhibition of bone metastasis.
描述(由申请人提供):美国癌症协会估计,2010年有超过32,000名男性死于前列腺癌转移是前列腺癌死亡的主要原因,最常见的转移部位是骨骨转移是无法治愈的,并伴有明显的疼痛和发病率。前列腺癌细胞在骨内转移和生长的机制尚不完全清楚,但我们假设Wnt信号通路是必不可少的。3-8虽然Wnt信号在前列腺癌骨转移中已被证明可刺激上皮-间质转化(EMT)和转移的典型成骨细胞表型,但其作用尚不清楚。9-11了解Wnt信号的作用将为预防或治疗前列腺癌骨转移提供新的治疗靶点,并将降低其发病率和死亡率。该项目旨在验证Wnt信号通路和DKK-1(典型Wnt信号的抑制剂和非典型Wnt信号的刺激剂)在前列腺癌增殖、进展和骨转移的调节中起重要作用的中心假设。这三个目的旨在测试:1)前列腺癌自分泌非典型Wnt信号是否会促进肿瘤生长;2)前列腺癌旁分泌典型Wnt信号诱导成骨细胞转移;3)骨吸收释放的因子与非典型Wnt通路共同促进前列腺癌的生长和转移。我们已经开发了一种独特的前列腺癌小鼠模型,使用犬Ace-1前列腺癌细胞来测试假设。Ace-1细胞只转移到长骨和脊柱,并诱导成骨细胞骨转移。此外,这些假设将通过小鼠颅骨和前列腺癌细胞的双室体外共培养和裸鼠的小泡(新生小鼠椎骨)/前列腺癌共植入来验证。拟议的F32奖学金研究培训计划将为Jessica Simmons, DVM提供强大的基础转化科学研究经验。Simmons博士是一位有抱负的科学家,他的研究兴趣集中在研究前列腺癌骨转移的发病机制。F32奖学金将支持Simmons博士的研究以及促进她的职业发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jessica Kelly Simmons其他文献

Jessica Kelly Simmons的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jessica Kelly Simmons', 18)}}的其他基金

Wnt Signaling and Prostate Cancer Bone Metastasis
Wnt 信号转导与前列腺癌骨转移
  • 批准号:
    8438524
  • 财政年份:
    2012
  • 资助金额:
    $ 5.13万
  • 项目类别:
Wnt Signaling and Prostate Cancer Bone Metastasis
Wnt 信号转导与前列腺癌骨转移
  • 批准号:
    8610261
  • 财政年份:
    2012
  • 资助金额:
    $ 5.13万
  • 项目类别:

相似海外基金

Elucidation of bone resorption mechanism around implants caused by microgap dissection and establishment of suppression method
微间隙剥离引起种植体周围骨吸收机制的阐明及抑制方法的建立
  • 批准号:
    22K10080
  • 财政年份:
    2022
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CAN OSTEOCLAST BIOMARKERS DETECT EXCESSIVE SUBCHONDRAL BONE RESORPTION IN RACEHORSES?
破骨细胞生物标志物可以检测赛马过度的软骨下骨吸收吗?
  • 批准号:
    RGPIN-2019-04966
  • 财政年份:
    2022
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Discovery Grants Program - Individual
Mechanisms of bone resorption in the cancer microenvironment.
癌症微环境中的骨吸收机制。
  • 批准号:
    22K10145
  • 财政年份:
    2022
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Secretory mechanism of GMSC derved exosomes and suppression of bone resorption by internalizing miRNA
GMSC 衍生的外泌体的分泌机制和通过内化 miRNA 抑制骨吸收
  • 批准号:
    21K21017
  • 财政年份:
    2021
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Bone Marrow Inflammation and Bone Resorption
骨髓炎症和骨吸收
  • 批准号:
    10295620
  • 财政年份:
    2021
  • 资助金额:
    $ 5.13万
  • 项目类别:
CAN OSTEOCLAST BIOMARKERS DETECT EXCESSIVE SUBCHONDRAL BONE RESORPTION IN RACEHORSES?
破骨细胞生物标志物可以检测赛马过度的软骨下骨吸收吗?
  • 批准号:
    RGPIN-2019-04966
  • 财政年份:
    2021
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Discovery Grants Program - Individual
Bone Marrow Inflammation and Bone Resorption
骨髓炎症和骨吸收
  • 批准号:
    10673929
  • 财政年份:
    2021
  • 资助金额:
    $ 5.13万
  • 项目类别:
A new model for spatio-temporal coupling of bone formation and bone resorption governed by osteoclasts
破骨细胞控制的骨形成和骨吸收时空耦合的新模型
  • 批准号:
    10905262
  • 财政年份:
    2020
  • 资助金额:
    $ 5.13万
  • 项目类别:
The Myokine Irisin Modulates Bone Resorption via Stimulation of Osteoclastogenesis
肌动素鸢尾素通过刺激破骨细胞生成调节骨吸收
  • 批准号:
    10228556
  • 财政年份:
    2020
  • 资助金额:
    $ 5.13万
  • 项目类别:
CAN OSTEOCLAST BIOMARKERS DETECT EXCESSIVE SUBCHONDRAL BONE RESORPTION IN RACEHORSES?
破骨细胞生物标志物可以检测赛马过度的软骨下骨吸收吗?
  • 批准号:
    RGPIN-2019-04966
  • 财政年份:
    2020
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了